Stockscreener 앱 받기
52.69
0.50%
0.26
시간 외 거래:
52.69
전일 마감가:
$52.43
열려 있는:
$52.69
하루 거래량:
1.60M
Relative Volume:
0.70
시가총액:
$8.24B
수익:
$1.22B
순이익/손실:
$81.07M
주가수익비율:
102.49
EPS:
0.5141
순현금흐름:
$223.02M
1주 성능:
+3.70%
1개월 성능:
-8.95%
6개월 성능:
+4.38%
1년 성능:
-12.15%
1일 변동 폭
$52.02
$53.23
1주일 범위
$50.02
$53.53
52주 변동 폭
$46.01
$72.16
바이오-테크네 Stock (TECH) Company Profile
명칭
Bio Techne Corp
전화
612-379-8854
주소
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Compare TECH vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
52.69 | 8.20B | 1.22B | 81.07M | 223.02M | 0.5141 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
바이오-테크네 Stock (TECH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2025-07-09 | 개시 | TD Cowen | Buy |
| 2025-05-30 | 개시 | Wells Fargo | Overweight |
| 2025-04-09 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-08 | 개시 | Scotiabank | Sector Outperform |
| 2024-02-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-08-28 | 개시 | William Blair | Outperform |
| 2023-01-10 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | 업그레이드 | Stifel | Hold → Buy |
| 2021-01-25 | 재확인 | The Benchmark Company | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-07-15 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-05-14 | 개시 | The Benchmark Company | Buy |
| 2020-01-08 | 재개 | Stephens | Overweight |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-02 | 업그레이드 | Janney | Neutral → Buy |
| 2019-01-14 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-10-17 | 개시 | Goldman | Neutral |
| 2018-06-15 | 개시 | Argus | Buy |
| 2017-07-13 | 개시 | Wells Fargo | Market Perform |
| 2017-02-09 | 개시 | Citigroup | Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Buy |
| 2016-11-10 | 재개 | Leerink Partners | Outperform |
| 2015-01-21 | 재확인 | Robert W. Baird | Outperform |
| 2013-09-20 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
모두보기
바이오-테크네 주식(TECH)의 최신 뉴스
Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite - The AI Journal
Bio-Techne expands spatial biology product portfolio - Investing.com
Bio-Techne adds tools aimed at harder-to-detect tissue targets - Stock Titan
Bio-Techne Sees Unusually Large Options Volume (NASDAQ:TECH) - MarketBeat
Bio-Techne Corp. stock rises Monday, still underperforms market - MarketWatch
Tudor Investment Corp ET AL Purchases Shares of 242,016 Bio-Techne Corp $TECH - MarketBeat
JPMorgan Chase Sells Stake in Bio-Techne Corp - National Today
JPMorgan Chase & Co. Sells 633,738 Shares of Bio-Techne Corp $TECH - MarketBeat
38,300 Shares in Bio-Techne Corp $TECH Purchased by Covea Finance - MarketBeat
After a Long Reset Period, Life Science Stocks Look Set to Rebound - Morningstar
How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks - Yahoo Finance
ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape - GlobeNewswire Inc.
TECH SEC FilingsBio-Techne Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Bio-Techne Corp (NASDAQ:TECH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
Bio-Techne Corp. stock underperforms Monday when compared to competitors - MSN
Should You Continue to Hold Bio-Techne Stock in Your Portfolio? - Yahoo Finance
Risk Check: Will Bio Techne Corporation outperform the market in YEAR2026 Levels & Fast Moving Market Watchlists - baoquankhu1.vn
Bio-Techne stock falls on AI software concerns, TD Cowen sees buy opportunity - Investing.com
Mairs & Power Inc. Has $156.18 Million Stock Position in Bio-Techne Corp $TECH - MarketBeat
April McClain Delaney makes multiple stock transactions in Bio-Techne, BJ’s Wholesale, and C.H Robinson - Investing.com Nigeria
Trading the Move, Not the Narrative: (TECH) Edition - Stock Traders Daily
Hollow Brook Wealth Management Increases Stake in Bio-Techne Corp - National Today
Bio-Techne Corp $TECH Shares Acquired by Hollow Brook Wealth Management LLC - MarketBeat
Bamco Inc. NY Sells Nearly 300,000 Shares of Bio-Techne Corp - National Today
Bamco Inc. NY Sells 298,824 Shares of Bio-Techne Corp $TECH - MarketBeat
Aristotle Atlantic Partners LLC Lowers Stock Position in Bio-Techne Corp $TECH - MarketBeat
ArrowMark Colorado Holdings LLC Has $18.69 Million Stock Position in Bio-Techne Corp $TECH - MarketBeat
2Xideas AG Sells 21,436 Shares of Bio-Techne Corp $TECH - MarketBeat
2Xideas AG Sells 21,436 Shares of Bio-Techne Corp - National Today
Assessing Bio‑Techne (TECH) Valuation After Institutional Buying Earnings Beat And New AI Drug Discovery Push - Yahoo Finance
Bio-Techne Corp. stock underperforms Friday when compared to competitors - MarketWatch
Is Bio-Techne Stock a Buy, Sell, or Hold After a Wealth Manager Dumps Its Entire Stake? - Yahoo Finance
Meridiem Capital Partners LP Makes New Investment in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Argus raises Bio-Techne stock price target on AI drug discovery tools - Investing.com Nigeria
Argus raises Bio-Techne stock price target on AI drug discovery tools By Investing.com - Investing.com South Africa
Mackenzie Financial Corp Sells 59,511 Shares of Bio-Techne Corp $TECH - MarketBeat
Capital Research Global Investors Grows Stock Position in Bio-Techne Corp $TECH - MarketBeat
Rep. April McClain Delaney Sells Bio-Techne Corp Shares - National Today
Rep. April McClain Delaney Sells Bio-Techne Corp (NASDAQ:TECH) Shares - MarketBeat
CEO Moves: How does Bio Techne Corporation perform in inflationary periods2026 Technicals & Technical Entry and Exit Tips - baoquankhu1.vn
WINTON GROUP Ltd Sells 69,994 Shares of Bio-Techne Corp $TECH - MarketBeat
Jefferies Financial Group Invests $2.43M in Bio-Techne Corp - National Today
Jefferies Financial Group Inc. Makes New $2.43 Million Investment in Bio-Techne Corp $TECH - MarketBeat
31,091 Shares in Bio-Techne Corp $TECH Bought by B. Metzler seel. Sohn & Co. AG - MarketBeat
Bio-Techne at Leerink Global Healthcare Conference: Strategic Growth Insights - Investing.com
Blair William & Co. IL Boosts Bio-Techne Corp Stake - National Today
Blair William & Co. IL Acquires 51,223 Shares of Bio-Techne Corp $TECH - MarketBeat
Is Bio-Techne (TECH) Now More a Macro Sentiment Story Than a Healthcare Innovation Play? - simplywall.st
Assessing Bio‑Techne (TECH) Valuation After Macro Jitters Hit Healthcare Stocks - simplywall.st
바이오-테크네 (TECH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):